Life-threatening skin reaction with Enfortumab Vedotin: Six cases
- PMID: 35346550
- DOI: 10.1016/j.ejca.2022.02.019
Life-threatening skin reaction with Enfortumab Vedotin: Six cases
Conflict of interest statement
Conflict of interest statement The authors declare the following financial interests/personal relationships that may be considered as potential competing interests. Florine Guerrois, Dr Coralie Lheure, Dr Pierre Sohier, Dr Benoit Bensaid, Dr Saskia Ingen-Housz-Oro, Pr Nicolas Dupin declare no competing financial interests. Dr Constance THIBAULT reports fees from BMS, AstraZeneca, Sanofi, Ipsen, Janssen, MSD, Pfizer, Merck, Astellas; grants from AstraZeneca, Sanofi; reimbursement for international meetings assistance from AstraZeneca, Ipsen, Janssen, Mylan; all outside the submitted work.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources